A strategic and technical advisory committee to the Consortium Executive Committee, the Advisory Committee provides counsel on new initiatives, health science or health policy issues, and other activities of the consortium.
Consortium members may participate in working committees. Please contact us.
Chair
Chee Jen Chang, PhD
Distinguished Professor, Chang Gung University
Ta An Distruct, TPE, Taiwan
Past Chair
Bruce Crawford, MPH, MA
Vice President, Real World & Late Phase, APAC, Syneos Health
Chuo ku, 13, Japan
Asia Consortium Advisory Committee Members
SeungJin Bae
Ewha Womans University
Seoul, South Korea
Nathorn Chaiyakunapruk, PharmD, PhD
Professor, University of Utah
Salt Lake City, UT, United States
Alex Fu, PhD
Director, Johnson & Johnson
Titusville, NJ, United States
Ruoyan Gai, MSc, PhD
Senior Research Officer, National Institute of Population and Social Security Research
Tokyo, 13, Japan
Jianfei (Jeff) Guo, RPh, PhD
Professor, University of Cincinnati College of Pharmacy
Cincinnati, OH, United States
Allen Yuhung Lai, MSc, PhD, MD, MPP
Regional Managing Director, ACT Genomics
Singapore, Singapore
Kenneth Lee
Monash University Malaysia
Kuala Lumpur, Malaysia
Vivian Lee, PharmD, BSc
Associate Professor, The Chinese University of Hong Kong
Shatin, Hong Kong
Hong Li, PhD, MPH
Lead, Amgen Asia Holding Limited
Cheshire, CT, United States
Shu Chuen Li, MSc, MBA, PhD, BSc
Chair Professor, University of Newcastle, School of Biomedical Sciences & Pharmacy
Callaghan NSW, Australia
Surachat Ngorsuraches, PhD
Associate Professor, Auburn University
Auburn, AL, United States
Xin Sun, MSc, PhD, BSc
Director, Chinese Evidence-based Medicine Center
Chengdu, China
Jenny Sung, MS, MBA, PharmD
Head, CV Health Economics and Outcomes Research, Novartis Pharmaceuticals Corporation
East Hanover, NJ, United States
Jing Wu, PhD
Professor, Tianjin University
Tianjin, 12, China
Jianwei Xuan, PhD, MD
Professor, Sun Yat-Sen University
Guangzhou, China
Ming-Chin Yang, DrPH
Professor, National Taiwan University
Taipei, TPE, Taiwan